Bayer is looking to accelerate its patient safety data monitoring by using artificial intelligence in a move it hopes will allow any potential drug-related side effects to be detected much earlier.

MadeAi™, CapeStart’s GenAI-Enabled Platform for the Life Sciences, wins in the Generative AI category,helping organizations better compete and win in the AI Economy CAMBRIDGE, MA March 25, ...

Big data, artificial intelligence (AI), and machine learning (ML) are driving a technological revolution in healthcare. But with such rapid progress, understanding what these advancements mean in ...

Hua Medicine Announces 2024 Annual Results - HuaTangNing completed its first full year for reimbursement under the National Reimbursement D ...

Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading ...

Eric and Wendy Schmidt and the Sorbonne will fund a new program to digitize Delacroix’s papers and identify other artists who may have contributed to his murals and paintings. By Frank Rose ...

Here's how Central Florida health care providers and experts are navigating the delicate balance between medical AI ...

Mar. 18, 2025 — Chemists have created a machine learning tool that can identify the chemical composition of dried salt solutions from an image with 99% accuracy. By ... Squirrel-Inspired Leaping ...

Researchers studying Alzheimer’s disease are using artificial intelligence-powered databases to accelerate the drug discovery process by making it easier to sift through vast amounts of biomedical ...

Health insurers are using more AI but a lack of transparency makes it difficult to understand the impact on patients ...